1 de marzo de 2025 Respiratory

Clearing the air, natural ways to soothe nasal congestion

Definition and impact of nasal congestion. Nasal congestion is a common symptom in upper respiratory conditions (such as rhinitis sinusitis, common cold, nasal surgery…) defined as the objective restriction of nasal cavity airflow caused by mucosal pathology and/or increased mucous secretions.

Read more
2 de septiembre de 2025 Cardiometabolic diseases

Clustering of metabolic risk factors in CVD: obesity, hypertension, insulin resistance, dyslipidaemia

Metabolic syndrome is a condition marked by a complex set of physiological, biochemical, and metabolic factors, such as abdominal obesity, insulin resistance, high blood pressure, and dyslipidaemia.

Read more
1 de julio de 2025 Cardiometabolic diseases

Hyperlipidaemia: when and how to start statin therapy

During the last decades, the prevalence of some non-communicable diseases, such as hyperlipidaemia, has been increasing globally. A recent meta-analysis conducted in the Middle East found a pooled prevalence of 32.09% for elevated low-density lipoprotein cholesterol (LDL-C).1 Increased blood levels of LDL-C, classified as hyperlipidaemia, is a well-established causal risk factor for atherosclerotic cardiovascular disease (ASCVD)

Read more
16 de septiembre de 2025 Cardiometabolic diseases

Hypertension in primary care: a need for long-term management

Thresholds for hypertension diagnosis differ depending if blood pressure (BP) is measured in the office, at home or ambulatory (daytime, night-time and 24 hours values) according to European guidelines.

Read more
16 de septiembre de 2025 Cardiometabolic diseases

LDL-C goals in international guidelines and how to achieve them

Across major guidelines, low-density lipoprotein cholesterol (LDL-C) remains the primary target for atherosclerotic cardiovascular disease (ASCVD) prevention, although other guidelines (e.g. United Kingdom) propose non-high-density lipoprotein cholesterol (non-HDL-C) as the main metric for monitoring ASCVD. The primary aim of LDL-C management is to achieve the lowest possible levels through appropriate treatment intensification, while tailoring it to the patient’s cardiovascular risk category, with particular attention to those at high or very high risk.

Read more
16 de septiembre de 2025 Cardiometabolic diseases

Obesity management: from lifestyle changes to medication and surgery

Obesity and overweight are a growing health issue. In 2022, 2.5 billion adults (18 years and older) were overweight, of these, 890 million were living with obesity, and these values are expected to continue rising in the following years. The consequences of obesity are vast, ranging from increased risk for cardiovascular diseases (CVDs) and type 2 diabetes, to impaired quality of life.

Read more
30 de junio de 2025 CNS

The first seizure:
risk of recurrence and when to initiate treatment

Unprovoked seizures are defined as events occurring in the absence of an acute systemic or cerebral insult. They are distinct from acute symptomatic seizures, which are triggered by reversible conditions such as infections, electrolyte imbalances, or substance withdrawal, and in which recurrence can be considered a rare event

Read more
30 de julio de 2025 Cardiometabolic diseases

The ticking clock of metabolic syndrome: why early detection matters

Metabolic syndrome is a complex set of interconnected physiological, biochemical, and metabolic factors that contribute to the development of several chronic conditions, such as cardiovascular disease or type 2 diabetes.

Read more
30 de julio de 2025 Respiratory

Why controlling inflammation may be the core of treatment in asthma

Despite decades of advances, asthma continues to affect over 260 million individuals globally, making it one of the most common non-communicable diseases (NCDs) worldwide and the leading chronic condition in children.

Read more